| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10912046 | Lung Cancer | 2005 | 8 Pages |
Abstract
VG compared to VC resulted in a similar overall response rate, favourable median survival and a better toxicity profile. For non-cisplatin-based chemotherapy, VG is a useful alternative.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
E.H. Tan, A. Szczesna, M. Krzakowski, H.N. Macha, U. Gatzemeier, K. Mattson, M. Wernli, P. Reiterer, R. Hui, J. Von Pawel, O. Bertetto, J.C. Pouget, J.P. Burillon, Y. Parlier, R. Abratt, On behalf of the GLOB 2 group On behalf of the GLOB 2 group,